IRIN Examines MDR-TB In Myanmar

IRIN examines the issue of multidrug-resistant tuberculosis (MDR-TB) in Myanmar, writing, “Inadequate detection and treatment are major obstacles and can result in cases of drug-resistant TB (DR-TB) such as MDR-TB, say health experts.” According to Peter Paul de Groote, Myanmar’s head of mission for Médecins Sans Frontières (MSF), “Drug-resistant TB is a very significant health concern for Myanmar,” the news service notes, adding, “Around 8,900 new cases of DR-TB are reported [in the country] each year, but only 800 patients had access to treatment at the end of 2012, he said.” IRIN writes, “From August 22 to 23, WHO, along with MSF and Myanmar’s Ministry of Health, plan to hold a DR-TB symposium in Yangon aimed at ramping up services throughout the country, including neglected border regions” (8/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.